Baker McKenzie is acting as international counsel to McKesson Corporation (NYSE: MCK) on its acquisition of Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization services for approximately USD 2.25 billion.
Led by M&A Partner Darcy Down, the core team included:
Corporate / M&A: Collin Stich, Angus Duncan
IP / Data: Adam Aft, Keo McKenzie, Robby Turner
Regulatory: Lois Sheng Liu, Jing Xu
Employment: Kimberly Franko, Benjamin Durst
Compensation: M’Alyssa Mecenas, Sesen Hailemichael, Jill Sparkman
Real Estate: Sarah Swain
Lawyers from around the Firm formed part of Baker McKenzie’s wider transactional team.
Learn more about the transaction: McKesson Signs Agreement to Acquire Precision Medicine Group, LLC
Baker McKenzie is a global transactional leader, with more than 2,500 deal practitioners across 40+ countries advising on complex and cross‑border transactions. With one of the largest Healthcare & Life Sciences teams of any international law firm, the Firm combines deep sector knowledge and a global platform to execute high‑stakes matters at the intersection of innovation, regulation and M&A.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
